CIK 0001781983
- Non-accelerated filer
- Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-30 | Seizinger Bernd R. Director | Grant or award · Stock Option (Right to Buy) | +22,750 | 22,750 | ||
| 2021-06-30 | Namouni Fouad Director | Grant or award | +4,610 | 4,610 | ||
| 2021-06-30 | Namouni Fouad Director | Grant or award · Stock Option (Right to Buy) | +22,750 | 22,750 | ||
| 2021-03-10 | Korbel Gregory Alan Chief Business Officer | Grant or award | +15,000 | 25,500 | ||
| 2021-02-25 | Attar Eyal C. SVP, Chief Medical Officer | Grant or award | +33,000 | 33,000 | ||
| 2021-02-25 | Attar Eyal C. SVP, Chief Medical Officer | Grant or award | +75,000 | 108,000 | ||
| 2021-02-25 | Attar Eyal C. SVP, Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +143,000 | 143,000 | ||
| 2021-02-25 | Wessels Gregory S. SVP, Chief Commercial Officer | Grant or award | +16,000 | 16,000 | ||
| 2021-02-25 | Wessels Gregory S. SVP, Chief Commercial Officer | Grant or award · Stock Option (right to Buy) | +66,000 | 66,000 | ||
| 2021-02-25 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Grant or award | +19,000 | 19,000 | ||
| 2021-02-25 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Grant or award · Stock Option (right to Buy) | +82,000 | 82,000 | ||
| 2021-02-25 | SCHADE CHRISTIAN S Chairman & CEO | Grant or award | +77,000 | 77,160 | ||
| 2021-02-25 | SCHADE CHRISTIAN S Chairman & CEO | Grant or award | +88,500 | 176,660 | ||
| 2021-02-25 | SCHADE CHRISTIAN S Chairman & CEO | Grant or award · Stock Option (right to Buy) | +329,000 | 329,000 | ||
| 2021-02-25 | Coiante Scott M SVP, Chief Financial Officer | Grant or award | +33,000 | 35,500 | ||
| 2021-02-25 | Coiante Scott M SVP, Chief Financial Officer | Grant or award | +63,500 | 99,000 | ||
| 2021-02-25 | Coiante Scott M SVP, Chief Financial Officer | Grant or award · Stock Option (right to Buy) | +143,000 | 143,000 | ||
| 2021-02-25 | Korbel Gregory Alan VP of Business Dev't | Grant or award | +10,000 | 10,500 | ||
| 2021-02-25 | Korbel Gregory Alan VP of Business Dev't | Grant or award · Stock Option (right to Buy) | +41,100 | 41,100 | ||
| 2020-12-28 | Redmile Group, LLC 10% owner | Sale | −494,137 | $5.58 | $2.8M | 1,774,581 |
Page 11 of 17 · 334 trades